Organization Profile
Pivotal Therapeutics is a publicly traded (CNSX:
PVO) specialty pharmaceutical company with a focus on the treatment of
cardiovascular diseases. Pivotal’s innovative and proprietary lead product,
VASCAZENTM, is a prescription grade, ultra-pure Omega 3 fatty acid
for the dietary management of cardiovascular disease in patients manifesting an
Omega 3 fatty acid deficiency.
Contact Information
Timothy J. Ryan
Managing Director
Tel: 212-242-7777
tryan@shorehamgroupllc.com
Rachelle MacSweeney
President
Tel: 905-856-9797
rmacsweeney@pivotaltherapeutics.us
Market Performance
Latest News Releases
